Ward, Anthony R.
Pratt, Mercedes
Lane, David M.
Aman, Michael G.
Loveland, Katherine A.
Mansour, Rosleen
Pearson, Deborah A. http://orcid.org/0000-0002-0284-5053
Article History
Accepted: 15 December 2021
First Online: 7 January 2022
Declarations
:
: Dr. Deborah Pearson has received travel reimbursement and research support from Curemark LLC; research support from Biomarin and Novartis, and has served as a consultant to Curemark LLC. Ms. Rosleen Mansour has received research support from Curemark LLC. Dr. Michael Aman has consulted with or served on advisory boards for Impel Neuropharm, Ovid Therapeutics, PaxMedica Biopharmaceutical, Supernus Pharmaceuticals, and Zynerba Pharmaceuticals. He receives royalties from Slosson Educational Publications. The other authors report no biomedical financial interests or potential conflicts of interest.
: All research procedures were approved by the Institutional Review Board for human subject research at the University of Texas Health Science Center at Houston and conformed to the Ethical Principles of Psychologists and Code of Conduct (American Psychological Association,CitationRef removed) and with the ethical standards laid down in the 1964 Declaration of Helsinki (and its later amendments and comparable ethical standards).
: Written informed consent was obtained from legal guardians.